Abstract
Gram-negative bacilli (GNB) are present in a large variety of infections. The prognosis of patients with infections by these germs largely depends on the initiation of the correct antibiotic treatment. The progressive increase in resistance in GNB worldwide to the different antibiotics at our disposal for their treatment has become a cause of concern and an additional complexity in establishing a correct empirical treatment. There is also a need for available protocols aimed at maximum optimisation of these treatments, bearing in mind the focus of infection, the environment of acquisition (hospital or community) and the local resistance of each centre for these bacteria.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callMore From: Medicine - Programa de Formación Médica Continuada acreditado
Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
